Johnson&Johnson (J&J) takes a step back. The American company announced this Thursday the global market withdrawal of its baby talcum powder after the accusations that ensure that this product can cause cancer.
The company has detailed that the product, called Johnson’s Baby Powder will no longer be sold worldwide from 2023, as announced in a statement. At the same time, J&J has announced the transition of the entire range of baby powder products to have a cornstarch-based composition.
“We continually evaluate and optimize our portfolio to better position the business for long-term growth; This transition will help simplify our product offerings, deliver sustainable innovation and meet the needs of our consumers.”
In 2017, J&J was forced to pay 417 million for considering that it was responsible for the ovarian cancer of a 63-year-old woman
J&J has maintained its position on the safety of its cosmetic talcum powder, maintaining that it does not contain asbestos and does not cause cancer. In 2017, a court in Los Angeles sentenced the pharmaceutical company to pay up to 417 million dollars (354 million euros then) considering that the group was responsible for terminal ovarian cancer diagnosed in a 63-year-old woman.
In addition, the company faces other legal problems in the United States and agreed earlier this year to pay millions of dollars to several states, along with other large drug distributors, for their responsibility in the opioid crisis.